Is MDB a buy, hold, or sell?
MDB carries a valuation grade of Reduce. Our discounted cash flow model produces an intrinsic range of $225–$415 — implying a -5% margin of safety at the current price of $335.55. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 11.5% earnings surprise. Analyst estimate revisions are trending downward.
What are MDB's key risk factors?
With a beta of 1.49, MDB exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -33.4% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 3.3% of total portfolio loss in the worst 5% of months. Net margins of -1.1% fall below the Technology sector average of 22%, suggesting margin pressure. The balance sheet is conservatively leveraged at 2% debt-to-equity.
A put/call ratio of 0.86 indicates roughly balanced sentiment in the options market. Implied volatility of 75.2% exceeds realized volatility of 67.7% by 8 points, suggesting options are pricing in elevated risk. Insiders have been net sellers to the tune of $142.8M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 5.0% of float, suggesting limited bearish conviction.
How does MDB fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — MDB carries a beta of 1.49, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, MDB shows the strongest co-movement with SNOW (0.55), MSFT (0.36), AMZN (0.17). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The MDB analysis here is a single node in that larger structure.
For analysis of the structural AI infrastructure capex cycle driving demand for MDB — see our thematic deep-dive: The $7 Trillion Race: AI Infrastructure as a Decade-Long Investment Cycle.
